Spots Global Cancer Trial Database for resectable cholangiocarcinoma
Every month we try and update this database with for resectable cholangiocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer | NCT03579771 | Resectable Chol... Stage IB Intrah... Stage II Intrah... Stage III Intra... Stage IIIA Intr... Stage IIIB Intr... | Cisplatin Gemcitabine Nab-paclitaxel | 19 Years - | Emory University |